Grand Pharmaceutical Group Limited (0512) Income Statement

4 Followers

Grand Pharmaceutical Group Limited Income Statement

Last quarter (Q4 2025), Grand Pharmaceutical Group Limited's total revenue was HK$6.18B, an increase of 36.03% from the same quarter last year. In Q4, Grand Pharmaceutical Group Limited's net income was HK$71.85M. See Grand Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	HK$ 12.28B	HK$ 11.64B	HK$ 10.53B	HK$ 9.56B	HK$ 8.60B
Gross Profit	HK$ 6.78B	HK$ 6.74B	HK$ 6.52B	HK$ 5.95B	HK$ 5.25B
Operating Expenses	HK$ 5.23B	HK$ 4.57B	HK$ 3.86B	HK$ 3.43B	HK$ 3.23B
Depreciation and Amortization	HK$ 581.89M	HK$ 503.75M	HK$ 392.21M	HK$ 394.91M	HK$ 339.52M
EBITDA	HK$ 2.13B	HK$ 3.39B	HK$ 2.97B	HK$ 3.09B	HK$ 3.10B
Operating Income	HK$ 1.55B	HK$ 2.17B	HK$ 2.66B	HK$ 2.52B	HK$ 2.02B
Other Income/Expenses	HK$ -51.58M	HK$ 680.33M	HK$ -319.20M	HK$ -731.00K	HK$ 767.25M
Pretax Income	HK$ 1.49B	HK$ 2.85B	HK$ 2.34B	HK$ 2.52B	HK$ 2.79B
Net Income	HK$ 1.24B	HK$ 2.47B	HK$ 1.88B	HK$ 2.08B	HK$ 2.40B
Per Share Metrics
Basic EPS	HK$ 0.35	HK$ 0.70	HK$ 0.54	HK$ 0.59	HK$ 0.68
Diluted EPS	HK$ 0.35	HK$ 0.70	HK$ 0.54	HK$ 0.59	HK$ 0.68
Weighted Average Shares Outstanding	3.50B	3.50B	3.51B	3.54B	3.55B
Weighted Average Shares Outstanding (Diluted)	3.50B	3.50B	3.51B	3.54B	3.55B

Currency in HKD

Grand Pharmaceutical Group Limited (0512) Income Statement

Grand Pharmaceutical Group Limited Income Statement

Grand Pharmaceutical Group Limited Earnings and Revenue History